Global Zika Virus Testing Market was valued at USD 131.9 million in 2016 and is estimated to grow significantly due to the growing demand for diagnostics from different parts of the world. Zika Virus is a disease by mosquitos that targets pregnant ladies especially the fetus. In 2016, there was a sudden outburst of the Zika Virus, which led to a massive demand for point-of-care testing diagnostic tests.
The diagnostic test is not location-specific with no special requirements for a special laboratory setup. The point-of-care test comprises RT-PCR, serology IgG/IgM Antibody detection, ELISA, and no laboratory organization. These tests are undertaken in riskier surroundings, which display harsh symptoms of Zika Virus-like fever in pregnancy along with rashes, muscle pain or joint pain, and conjunctivitis. The disease can be transferred from one individual to another either by sexual contact or from mother to fetus while pregnancy. The disease-prevention planning and funding therapeutic and are expected to boost the market growth in the coming years with a CAGR of 7.6%.
No proper vaccination has been found against Zika Virus to date despite the extensive ongoing research; hence to relieve the symptoms care and comfort are the only way to deal with this situation. Zika Virus detection kit is available for qualitative tests that help detect RNA of Zika Virus from the body samples like plasma, urine, and serum. After detection of the Zika Virus is in the body, antibodies Immunoglobulin M (IgM) are developed against the virus. The Zika Virus RNA detection test and the positive serum test for Immunoglobulin M (IgM) are performed to check and ascertain the presence of the Zika Virus in the body.
The research and development activities have been increased by the leading market players due to the government initiatives for the emergence of enhanced tests for detecting the Zika Virus. The speedy growing prevalence of Zika Virus testing infection, increasing awareness regarding early detection, and rising efforts by the manufacturers to introduce Zika Virus detection tests are predicted to drive the market growth. Moreover, the slow speed of adoption of modern technologies & lack of awareness in emerging nations, and enormous costs of branded test kits are estimated to bring obstacles in the growth of the Zika Virus Testing Market shortly. Also, incorrect results from defective diagnostic techniques can affect the Zika Virus Testing Market.
Currently, the Zika Virus detection is done given clinical manifestations. The serological devices and molecular detection are also important. Since the segmentation of this virus is difficult, NASBA, LFAs, and LAMP help in detecting and confirming the reason behind fever. These new techniques have supported faster and accurate detection of the virus.
The market is categorized based on test type, end-user, and geography. Based on test type, the market is divided into serological tests and molecular diagnostic tests which are also called nucleic acid amplification tests. The commonly used test is the molecular diagnostic test. It is (RT-PCR) Reverse Transcriptase Polymerase Chain Reaction that detects the existence of the Zika virus in human serum. The serological tests are dependent on the detection of IgM and IgG antibodies in the human serum by ELISA-based tests. Based on end-user, the Zika Virus Testing Market can be divided into diagnostic & pathological laboratories, contract research organizations, hospitals, and academic & research institutes.
Geographically, the market is segmented into Latin America, North America, Asia Pacific, Europe, and Middle East & Africa. North America is expected to dominate the market largely in the coming years due to the speedy growth of the Zika virus in the region. After North America, Europe is expected to contribute to the Zika Virus Testing Market at a significant pace. The Zika Virus Testing Market in the Asia Pacific is predicted to grow in the coming years owing to the increasing awareness of the Zika Virus and the emerging healthcare industry in the area. The prominent players in the Zika Virus Testing Industry are ARUP Laboratories, Luminex Corporation, Hologic, Siemens Healthcare Diagnostics, and Roche Molecular Systems.
Zika Virus Testing Test Type Outlook (Revenue, USD Million, 2016 - 2027)
• Nucleic Acid Amplification Testing (NAAT)
• Serological Testing
Zika Virus Testing Regional Outlook (Revenue, USD Million, 2016 - 2027)
• U.S. States & Territories
• U.S. States
• U.S. Territories
• Continental Europe
• the Asia Pacific
• Latin America
Research Support Specialist, USA
FREE sample contains market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...